Product Code: TMRGL80830
TMR's report on the global non-invasive brain stimulation system market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global non-invasive brain stimulation system market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global non-invasive brain stimulation system market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the non-invasive brain stimulation system market.
The report delves into the competitive landscape of the global non-invasive brain stimulation system market. Key players operating in the global non-invasive brain stimulation system market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global non-invasive brain stimulation system market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
- 2.1. Assumptions and Acronyms Used
- 2.2. Research Methodology
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunity
- 4.3. Global Non-invasive Brain Stimulation System Market Forecast
- 4.4. Global Non-invasive Brain Stimulation System Market Outlook
5. Market Outlook
- 5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
- 5.2. Key product/Brand Analysis
- 5.3. Diseases Epidemiology
- 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Product Type
- 6.1. Introduction
- 6.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
- 6.3. Global Non-invasive Brain Stimulation System Market Forecast, by Product Type
- 6.3.1. Transcranial Magnetic Stimulation (TMS) System
- 6.3.2. Transcranial Current Stimulation (TCS) System
- 6.4. Global Non-invasive Brain Stimulation System Market Analysis, by Product Type
7. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Application
- 7.1. Introduction
- 7.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
- 7.3. Global Non-invasive Brain Stimulation System Market Forecast, by Application
- 7.3.1. Depression
- 7.3.2. Epilepsy
- 7.3.3. Parkinson's Disease
- 7.3.4. Chronic Pain
- 7.3.5. Others
- 7.4. Global Non-invasive Brain Stimulation System Market Analysis, by Application
8. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by End-user
- 8.1. Introduction
- 8.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
- 8.3. Global Non-invasive Brain Stimulation System Market Forecast, by End-user
- 8.3.1. Hospitals
- 8.3.2. Ambulatory Surgical Centers
- 8.3.3. Specialty Clinics
- 8.3.4. Others
- 8.4. Global Non-invasive Brain Stimulation System Market Analysis, by End-user
9. Global Non-invasive Brain Stimulation System Market Analysis, by Region
- 9.1. Global Non-invasive Brain Stimulation System Market Analysis, by Region
- 9.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Region
- 9.3. Global Non-invasive Brain Stimulation System Market Forecast, by Region
- 9.3.1. North America
- 9.3.2. Europe
- 9.3.3. Asia Pacific
- 9.3.4. Latin America
- 9.3.5. Middle East & Africa
10. North America Non-invasive Brain Stimulation System Market Analysis
- 10.1. North America Non-invasive Brain Stimulation System Market Overview
- 10.2. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
- 10.3. North America Non-invasive Brain Stimulation System Market Forecast, by Country
- 10.3.1. U.S.
- 10.3.2. Canada
- 10.4. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
- 10.5. North America Non-invasive Brain Stimulation System Market Forecast, by Product Type
- 10.5.1. Transcranial Magnetic Stimulation (TMS) System
- 10.5.2. Transcranial Current Stimulation (TCS) System
- 10.6. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
- 10.7. North America Non-invasive Brain Stimulation System Market Forecast, by Application
- 10.7.1. Depression
- 10.7.2. Epilepsy
- 10.7.3. Parkinson's Disease
- 10.7.4. Chronic Pain
- 10.7.5. Others
- 10.8. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
- 10.9. North America Non-invasive Brain Stimulation System Market Forecast, by End-user
- 10.9.1. Hospitals
- 10.9.2. Ambulatory Surgical Centers
- 10.9.3. Specialty Clinics
- 10.9.4. Others
11. Europe Non-invasive Brain Stimulation System Market Analysis
- 11.1. Europe Non-invasive Brain Stimulation System Market Overview
- 11.2. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
- 11.3. Europe Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
- 11.3.1. Germany
- 11.3.2. U.K.
- 11.3.3. France
- 11.3.4. Italy
- 11.3.5. Spain
- 11.3.6. Rest of Europe
- 11.4. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
- 11.5. Europe Non-invasive Brain Stimulation System Market Forecast, by Product Type
- 11.5.1. Transcranial Magnetic Stimulation (TMS) System
- 11.5.2. Transcranial Current Stimulation (TCS) System
- 11.6. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
- 11.7. Europe Non-invasive Brain Stimulation System Market Forecast, by Application
- 11.7.1. Depression
- 11.7.2. Epilepsy
- 11.7.3. Parkinson's Disease
- 11.7.4. Chronic Pain
- 11.7.5. Others
- 11.8. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
- 11.9. Europe Non-invasive Brain Stimulation System Market Forecast, by End-user
- 11.9.1. Hospitals
- 11.9.2. Ambulatory Surgical Centers
- 11.9.3. Specialty Clinics
- 11.9.4. Others
12. Asia Pacific Non-invasive Brain Stimulation System Market Analysis
- 12.1. Asia Pacific Non-invasive Brain Stimulation System Market Overview
- 12.2. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
- 12.3. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
- 12.3.1. China
- 12.3.2. India
- 12.3.3. Japan
- 12.3.4. Australia & New Zealand
- 12.3.5. Rest of Asia Pacific
- 12.4. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
- 12.5. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Product Type
- 12.5.1. Transcranial Magnetic Stimulation (TMS) System
- 12.5.2. Transcranial Current Stimulation (TCS) System
- 12.6. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
- 12.7. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Application
- 12.7.1. Depression
- 12.7.2. Epilepsy
- 12.7.3. Parkinson's Disease
- 12.7.4. Chronic Pain
- 12.7.5. Others
- 12.8. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
- 12.9. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by End-user
- 12.9.1. Hospitals
- 12.9.2. Ambulatory Surgical Centers
- 12.9.3. Specialty Clinics
- 12.9.4. Others
13. Latin America Non-invasive Brain Stimulation System Market Analysis
- 13.1. Latin America Non-invasive Brain Stimulation System Market Overview
- 13.2. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
- 13.3. Latin America Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
- 13.3.1. Brazil
- 13.3.2. Mexico
- 13.3.3. Rest of Latin America
- 13.4. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
- 13.5. Latin America Non-invasive Brain Stimulation System Market Forecast, by Product Type
- 13.5.1. Transcranial Magnetic Stimulation (TMS) System
- 13.5.2. Transcranial Current Stimulation (TCS) System
- 13.6. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
- 13.7. Latin America Non-invasive Brain Stimulation System Market Forecast, by Application
- 13.7.1. Depression
- 13.7.2. Epilepsy
- 13.7.3. Parkinson's Disease
- 13.7.4. Chronic Pain
- 13.7.5. Others
- 13.8. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
- 13.9. Latin America Non-invasive Brain Stimulation System Market Forecast, by End-user
- 13.9.1. Hospitals
- 13.9.2. Ambulatory Surgical Centers
- 13.9.3. Specialty Clinics
- 13.9.4. Others
14. Middle East & Africa Non-invasive Brain Stimulation System Market Analysis
- 14.1. Middle East & Africa Non-invasive Brain Stimulation System Market Overview
- 14.2. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
- 14.3. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
- 14.3.1. GCC Countries
- 14.3.2. South Africa
- 14.3.3. Rest of Middle East & Africa
- 14.4. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
- 14.5. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Product Type
- 14.5.1. Transcranial Magnetic Stimulation (TMS) System
- 14.5.2. Transcranial Current Stimulation (TCS) System
- 14.6. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
- 14.7. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Application
- 14.7.1. Depression
- 14.7.2. Epilepsy
- 14.7.3. Parkinson's Disease
- 14.7.4. Chronic Pain
- 14.7.5. Others
- 14.8. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
- 14.9. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by End-user
- 14.9.1. Hospitals
- 14.9.2. Ambulatory Surgical Centers
- 14.9.3. Specialty Clinics
- 14.9.4. Others
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Company Profiles
- 15.2.1. Brainbox Ltd.
- 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.1.2. Product Portfolio
- 15.2.1.3. Financial Overview
- 15.2.1.4. Strategic Overview
- 15.2.1.5. SWOT Analysis
- 15.2.2. BrainsWay
- 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.2.2. Product Portfolio
- 15.2.2.3. Strategic Overview
- 15.2.2.4. SWOT Analysis
- 15.2.3. eNeura, Inc.
- 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.3.2. Product Portfolio
- 15.2.3.3. Strategic Overview
- 15.2.3.4. SWOT Analysis
- 15.2.4. Flow Neuroscience
- 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.4.2. Product Portfolio
- 15.2.4.3. Strategic Overview
- 15.2.4.4. SWOT Analysis
- 15.2.5. Magnus Medical, Inc.
- 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.5.2. Product Portfolio
- 15.2.5.3. Strategic Overview
- 15.2.5.4. SWOT Analysis
- 15.2.6. Magstim
- 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.6.2. Product Portfolio
- 15.2.6.3. Strategic Overview
- 15.2.6.4. SWOT Analysis
- 15.2.7. MagVenture
- 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.7.2. Product Portfolio
- 15.2.7.3. Strategic Overview
- 15.2.7.4. SWOT Analysis
- 15.2.8. NeoSync, Inc. (Wave Neuroscience, Inc.)
- 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.8.2. Product Portfolio
- 15.2.8.3. Strategic Overview
- 15.2.8.4. SWOT Analysis
- 15.2.9. NeuraLace
- 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.9.2. Product Portfolio
- 15.2.9.3. Strategic Overview
- 15.2.9.4. SWOT Analysis
- 15.2.10. neurocare group AG
- 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.10.2. Product Portfolio
- 15.2.10.3. Strategic Overview
- 15.2.10.4. SWOT Analysis
- 15.2.11. NeuroMetrix
- 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.11.2. Product Portfolio
- 15.2.11.3. Strategic Overview
- 15.2.11.4. SWOT Analysis
- 15.2.12. Neuronetics
- 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.12.2. Product Portfolio
- 15.2.12.3. Strategic Overview
- 15.2.12.4. SWOT Analysis
- 15.2.13. Soterix Medical, Inc.
- 15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.13.2. Product Portfolio
- 15.2.13.3. Strategic Overview